Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.09
$0.010.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.54% | -11.74% | 11.94% | -32.16% | -4.03% |
| Total Depreciation and Amortization | 4.08% | 0.00% | -2.00% | -5.66% | -34.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.87% | 120.53% | -52.50% | 77.82% | -39.84% |
| Change in Net Operating Assets | 187.57% | -212.26% | -37.77% | 4,951.64% | 112.20% |
| Cash from Operations | -15.86% | -60.61% | -2.39% | 6.32% | -1.08% |
| Capital Expenditure | 0.00% | 14.29% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.68% | 139.31% | -390.96% | 10.68% | -2.10% |
| Cash from Investing | -18.68% | 139.29% | -390.99% | 10.68% | -2.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 2,515.75% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 2,515.75% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.48% | -306.49% | -78.25% | 506.56% | -32.78% |